2024年度欣博盛自產(chǎn)試劑盒獎學(xué)金計劃
使用欣博盛品牌(NeoBioscience)ELISA試劑盒在 SCI 期刊上發(fā)表學(xué)術(shù)文章,
文章中注明試劑盒購自“ NeoBioscience Technology Co. Ltd. ”,
滿足條件,即可申請獎勵!
現(xiàn)獎學(xué)金申請可優(yōu)先讓客戶通過官網(wǎng)填報(網(wǎng)址:獎學(xué)金申請 - 欣博盛生物 (neobioscience.net)),
但仍可直接通過原本的郵件/業(yè)務(wù)員/經(jīng)銷商等方式聯(lián)系。
使用欣博盛品牌(Neobioscience) ELISA試劑盒在SCI期刊上發(fā)表學(xué)術(shù)文章并注明試劑盒購自“Neobioscience Technology Co,Ltd.”
官網(wǎng)申請:登錄? ?www.neobioscience.net? ? ?在”獎學(xué)金申請”頁面在線提交申請表。
收到您的獎學(xué)金申請后,欣博盛生物將在7個工作日內(nèi)審核并處理。審核通過后,將根據(jù)您文章的影響因子(IF)發(fā)放獎勵。
IF越高,獎勵越多!欣博盛生物祝您多發(fā)Paper多拿獎勵!
●?申請文章需于2024年發(fā)表(以見刊時間為準(zhǔn)),文章影響因子(IF)以申請時該期刊的數(shù)據(jù)為準(zhǔn);
●?獲獎老師為文章第一作者或共同第一作者,每篇文章僅能申請一次獎勵;
●?文章內(nèi)使用指標(biāo)與購買的試劑盒指標(biāo)須一致;
●?以96T試劑盒為單位計算,申請文章總數(shù)不能多于三年內(nèi)購買試劑盒的總數(shù);
●?購物金僅限購買欣博盛ELISA時從單筆訂單中抵扣;
●?本活動最終解釋權(quán)歸欣博盛生物所有。
期刊:Translational Oncology, 2023
首都醫(yī)科大學(xué)宣武醫(yī)院-張老師
使用產(chǎn)品:Human IFN-γ and TNF-α ELISA Kit
●?我用過貴公司的多種細(xì)胞因子的ELISA檢測試劑盒,包括顆粒酶B和穿孔素等。首先覺得試劑盒的質(zhì)量就很好,每次檢測后標(biāo)準(zhǔn)曲線均一性不錯,數(shù)據(jù)的可重復(fù)性強(qiáng)。其次試劑盒使用方便,簡單,說明書寫得很明確,操作起來可重復(fù)性也很好??傊?,使用貴公司的ELISA試劑盒體驗(yàn)極佳,接下來的科研工作如果做到ELISA實(shí)驗(yàn),也會首選欣博盛的產(chǎn)品。
期刊:Annals of the New York Academy of Sciences, 2023
武漢大學(xué)口腔醫(yī)院-彭老師
使用產(chǎn)品:Mouse IL-1β ELISA Kit
●?非常方便,并且說明書上的步驟也非常詳細(xì),上手很快,反應(yīng)也比較靈敏,副孔之間以及每次重復(fù)的結(jié)果相差都不大,擬合出來的標(biāo)準(zhǔn)曲線R2值比較高,可信度也很不錯。
期刊:Immunity, 2023
南方醫(yī)科大學(xué)-曾老師
使用產(chǎn)品:Mouse TNF-α, IL-1β, IL-6 and IL-18 ELISA Kits
●?我用過好多欣博盛ELISA試劑盒,包括鼠的IL-1β、TNF-α等,總體感覺不錯。比起進(jìn)口試劑盒,價格要公道便宜的多;與國內(nèi)其他公司相比,應(yīng)該算是國產(chǎn)頂級梯隊的產(chǎn)品了,值得信賴。
●?LV J W Y, YIN J H, et al. 2023. The tumor immune microenvironment of nasopharyngeal carcinoma after gemcitabine plus cisplatin treatment. Nature Medicine [J], 6 June 2023. (IF=82.9)
●?SHI X, SUN Q, HOU Y, et al. 2023. Recognition and maturation of IL-18 by caspase-4 noncanonical inflammasome. Nature [J], 22 November 2023. (IF=64.8)
●?CHEN X W R, LI L, et al. 2023. Pregnancy-induced changes to the gut microbiota drive macrophage pyroptosis and exacerbate septic inflammation. Immunity [J], 14 February 2023. (IF=32.4)
●?CHENG J Y J, LIU Y, et al. 2023. Cancer-cell-derived fumarate suppresses the anti-tumor capacity of CD8+ T cells in the tumor microenvironment. Cell Metabolism [J], 12 May 2023. (IF=29)
●?ZENG Y W R, WANG F, et al. 2023. Liberation of daidzein by gut microbial β-galactosidase suppresses acetaminophen-induced hepatotoxicity in mice. Cell Host & Microbe [J], 25 April 2023. (IF=30.3)
●?LIANG W Y Y, GONG S, et al. 2023. Airway dysbiosis accelerates lung function decline in chronic obstructive pulmonary disease. Cell Host & Microbe [J], 15 May 2023. (IF=30.3)
●?LIU W Z S, LI Q, et al. 2023. Lactate modulates iron metabolism by binding soluble adenylyl cyclase. Cell Metabolism [J], 21 July 2023. (IF=29)
●?WANG J Z L, WU N, et al. 2023. Inhibition of Phosphoglycerate dehydrogenase induces ferroptosis and overcomes enzalutamide resistance in castration-resistant prostate cancer cells. Drug Resistance Updates [J], 14 June 2023. (IF=24.3)
●?GUO Y Z X N, SU S, et al. 2023. β-adrenoreceptor-triggered PKA activation negatively regulates the innate antiviral response. Cellular & Molecular Immunology [J], 5 January 2023. (IF=24.1)
●?SHI Y S J, SUN Y, et al. 2023. A Hierarchical 3D Graft Printed with Nanoink for Functional Craniofacial Bone Restoration. Advanced Functional Materials [J], 6 June 2023. (IF=19)
●?LI X L Z, WANG P, et al. 2023. Dopamine‐Integrated Nanointerface between Fibrillar Matrix and Hydrophilic Nanohydroxyapatite Regulates Immune Microenvironment to Boost Endogenous Bone Regeneration. Advanced Functional Materials [J], 17January 2023. (IF=19)
●?ZHANG X Y Y, LI J, et al. 2023. Engineered Oxygen Factories Synergize with STING Agonist to Remodel Tumor Microenvironment for Cancer Immunotherapy. Advanced Functional Materials [J], 19 June 2023. (IF=19)
●?ZHANG L H S, MOVAHEDI F, ET AL. 2023. Amyloid-β/Tau burden and neuroinflammation dual-targeted nanomedicines synergistically restore memory and recognition of Alzheimer’s disease mice. Nano Today [J], 20 February 2023. (IF=17.4)
●?SHI X, SUN Q, HOU Y, et al. 2023. Recognition and maturation of IL-18 by caspase-4 noncanonical inflammasome. Nature [J], 624: 442-450.
●?ZHOU P, SHE Y, DONG N, et al. 2018. Alpha-kinase 1 is a cytosolic innate immune receptor for bacterial ADP-heptose. Nature [J], 561: 122-126.
●?SHI J, ZHAO Y, WANG K, et al. 2015. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature [J], 526: 660-665.
●?XU H, YANG J, GAO W, et al. 2014. Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome. Nature [J], 513: 237-241.
●?ZHAO Y, YANG J, SHI J, et al. 2011. The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature [J], 477: 596-600.
欣博盛生物科技有限公司?
全國服務(wù)熱線: 4006-800-892? ? ? ? ? ??郵箱: market@neobioscience.com?
深圳: 0755-26755892?????北京:?010-88594029? ? ? ?上海:?021-34613729? ? ??
廣州: 020-87615159? ? ? ?香港:?852-69410778?
代理品牌網(wǎng)站: m.yuebanme.com?
自主品牌網(wǎng)站: www.neobioscience.net?